HCC patients with TH and lower BOLA2 expression had higher levels of NRF2, whereas patients with higher BOLA2 expression had increased ATG4B, p62 and Keap1 levels (Figure 4B). The gene discussed is KEAP1; the disease is hepatocellular carcinoma.